BioRestorative Therapies presents at ORS 2025; VP Silva discusses development programs

BioRestorative Therapies, Inc.

Francisco Silva, VP of R&D, presented at Orthopaedic Research Society 2025 Annual Meeting on Feb 8.
Presentation materials will be posted on company website for 90 days under Scientific Publications.
No financial or clinical results from the presentation disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.